5 Buy-Rated Stocks with Latest Insider Purchases

Page 5 of 5

1. BioRestorative Therapies Inc (NASDAQ:BRTX)

Average Analyst Price Target: $12.5

Upside Potential: 830%

BioRestorative Therapies Inc (NASDAQ:BRTX) is working on  cell-based therapies to treat chronic lumbar disc disease and metabolic conditions. According to Yahoo Finance data the average analyst price estimate for the stock is about $12.  It was trading at $1.33 as of April 12.

On April 8, BioRestorative Therapies Inc’s (NASDAQ:BRTX) VP of R&D Francisco Silva snapped up 8,308 shares of BioRestorative Therapies Inc (NASDAQ:BRTX) at $1.23 per share. Since then the stock has gained about 4.7%.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 10 Underperforming Stocks Insiders are Buying and the Insiders Are Buying These 11 Penny Stocks.

Page 5 of 5